370 related articles for article (PubMed ID: 29526696)
1. LKB1, Salt-Inducible Kinases, and MEF2C Are Linked Dependencies in Acute Myeloid Leukemia.
Tarumoto Y; Lu B; Somerville TDD; Huang YH; Milazzo JP; Wu XS; Klingbeil O; El Demerdash O; Shi J; Vakoc CR
Mol Cell; 2018 Mar; 69(6):1017-1027.e6. PubMed ID: 29526696
[TBL] [Abstract][Full Text] [Related]
2. Salt-inducible kinase inhibition suppresses acute myeloid leukemia progression in vivo.
Tarumoto Y; Lin S; Wang J; Milazzo JP; Xu Y; Lu B; Yang Z; Wei Y; Polyanskaya S; Wunderlich M; Gray NS; Stegmaier K; Vakoc CR
Blood; 2020 Jan; 135(1):56-70. PubMed ID: 31697837
[TBL] [Abstract][Full Text] [Related]
3. The tumor suppressor kinase LKB1 activates the downstream kinases SIK2 and SIK3 to stimulate nuclear export of class IIa histone deacetylases.
Walkinshaw DR; Weist R; Kim GW; You L; Xiao L; Nie J; Li CS; Zhao S; Xu M; Yang XJ
J Biol Chem; 2013 Mar; 288(13):9345-62. PubMed ID: 23393134
[TBL] [Abstract][Full Text] [Related]
4. Feeding and Fasting Signals Converge on the LKB1-SIK3 Pathway to Regulate Lipid Metabolism in Drosophila.
Choi S; Lim DS; Chung J
PLoS Genet; 2015 May; 11(5):e1005263. PubMed ID: 25996931
[TBL] [Abstract][Full Text] [Related]
5. MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia.
Brown FC; Still E; Koche RP; Yim CY; Takao S; Cifani P; Reed C; Gunasekera S; Ficarro SB; Romanienko P; Mark W; McCarthy C; de Stanchina E; Gonen M; Seshan V; Bhola P; O'Donnell C; Spitzer B; Stutzke C; Lavallée VP; Hébert J; Krivtsov AV; Melnick A; Paietta EM; Tallman MS; Letai A; Sauvageau G; Pouliot G; Levine R; Marto JA; Armstrong SA; Kentsis A
Cancer Discov; 2018 Apr; 8(4):478-497. PubMed ID: 29431698
[TBL] [Abstract][Full Text] [Related]
6. Interaction between salt-inducible kinase 2 and protein phosphatase 2A regulates the activity of calcium/calmodulin-dependent protein kinase I and protein phosphatase methylesterase-1.
Lee CW; Yang FC; Chang HY; Chou H; Tan BC; Lee SC
J Biol Chem; 2014 Jul; 289(30):21108-19. PubMed ID: 24841198
[TBL] [Abstract][Full Text] [Related]
7. Salt-inducible kinase 2 and -3 are downregulated in adipose tissue from obese or insulin-resistant individuals: implications for insulin signalling and glucose uptake in human adipocytes.
Säll J; Pettersson AM; Björk C; Henriksson E; Wasserstrom S; Linder W; Zhou Y; Hansson O; Andersson DP; Ekelund M; Degerman E; Stenkula KG; Laurencikiene J; Göransson O
Diabetologia; 2017 Feb; 60(2):314-323. PubMed ID: 27807598
[TBL] [Abstract][Full Text] [Related]
8. Targeting SIK3 to modulate hippocampal synaptic plasticity and cognitive function by regulating the transcription of HDAC4 in a mouse model of Alzheimer's disease.
Dai X; Lin A; Zhuang L; Zeng Q; Cai L; Wei Y; Liang H; Gao W; Zhang J; Chen X
Neuropsychopharmacology; 2024 May; 49(6):942-952. PubMed ID: 38057370
[TBL] [Abstract][Full Text] [Related]
9. AMPKα-like proteins as LKB1 downstream targets in cell physiology and cancer.
Molina E; Hong L; Chefetz I
J Mol Med (Berl); 2021 May; 99(5):651-662. PubMed ID: 33661342
[TBL] [Abstract][Full Text] [Related]
10. 14-3-3 proteins mediate inhibitory effects of cAMP on salt-inducible kinases (SIKs).
Sonntag T; Vaughan JM; Montminy M
FEBS J; 2018 Feb; 285(3):467-480. PubMed ID: 29211348
[TBL] [Abstract][Full Text] [Related]
11. The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation.
Green AS; Chapuis N; Maciel TT; Willems L; Lambert M; Arnoult C; Boyer O; Bardet V; Park S; Foretz M; Viollet B; Ifrah N; Dreyfus F; Hermine O; Moura IC; Lacombe C; Mayeux P; Bouscary D; Tamburini J
Blood; 2010 Nov; 116(20):4262-73. PubMed ID: 20668229
[TBL] [Abstract][Full Text] [Related]
12. 1,25-Dihydroxyvitamin D3 induces monocytic differentiation of human myeloid leukemia cells by regulating C/EBPβ expression through MEF2C.
Zheng R; Wang X; Studzinski GP
J Steroid Biochem Mol Biol; 2015 Apr; 148():132-7. PubMed ID: 25448741
[TBL] [Abstract][Full Text] [Related]
13. High-Throughput Implementation of the NanoBRET Target Engagement Intracellular Kinase Assay to Reveal Differential Compound Engagement by SIK2/3 Isoforms.
Jin HY; Tudor Y; Choi K; Shao Z; Sparling BA; McGivern JG; Symons A
SLAS Discov; 2020 Feb; 25(2):215-222. PubMed ID: 31849250
[TBL] [Abstract][Full Text] [Related]
14. The FLT3 internal tandem duplication mutation is a secondary target of the aurora B kinase inhibitor AZD1152-HQPA in acute myelogenous leukemia cells.
Grundy M; Seedhouse C; Shang S; Richardson J; Russell N; Pallis M
Mol Cancer Ther; 2010 Mar; 9(3):661-72. PubMed ID: 20159992
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL- and mutant FLT3-expressing cells.
Weisberg E; Banerji L; Wright RD; Barrett R; Ray A; Moreno D; Catley L; Jiang J; Hall-Meyers E; Sauveur-Michel M; Stone R; Galinsky I; Fox E; Kung AL; Griffin JD
Blood; 2008 Apr; 111(7):3723-34. PubMed ID: 18184863
[TBL] [Abstract][Full Text] [Related]
16. PTHrP targets salt-inducible kinases, HDAC4 and HDAC5, to repress chondrocyte hypertrophy in the growth plate.
Nishimori S; Wein MN; Kronenberg HM
Bone; 2021 Jan; 142():115709. PubMed ID: 33148508
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of HDAC5 by SIK1 in AICAR-treated C2C12 myoblasts.
Takemori H; Katoh Hashimoto Y; Nakae J; Olson EN; Okamoto M
Endocr J; 2009; 56(1):121-30. PubMed ID: 18946175
[TBL] [Abstract][Full Text] [Related]
18. Salt-inducible Kinase 3 Signaling Is Important for the Gluconeogenic Programs in Mouse Hepatocytes.
Itoh Y; Sanosaka M; Fuchino H; Yahara Y; Kumagai A; Takemoto D; Kagawa M; Doi J; Ohta M; Tsumaki N; Kawahara N; Takemori H
J Biol Chem; 2015 Jul; 290(29):17879-17893. PubMed ID: 26048985
[TBL] [Abstract][Full Text] [Related]
19. SIK2 regulates CRTCs, HDAC4 and glucose uptake in adipocytes.
Henriksson E; Säll J; Gormand A; Wasserstrom S; Morrice NA; Fritzen AM; Foretz M; Campbell DG; Sakamoto K; Ekelund M; Degerman E; Stenkula KG; Göransson O
J Cell Sci; 2015 Feb; 128(3):472-86. PubMed ID: 25472719
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation-dependent degradation of MEF2C contributes to regulate G2/M transition.
Badodi S; Baruffaldi F; Ganassi M; Battini R; Molinari S
Cell Cycle; 2015; 14(10):1517-28. PubMed ID: 25789873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
